Ba. Morrow et al., STRESS ACTIVATION OF MESOCORTICOLIMBIC DOPAMINE NEURONS - EFFECTS OF A GLYCINE NMDA RECEPTOR ANTAGONIST, European journal of pharmacology, 238(2-3), 1993, pp. 255-262
Restraint of brief duration causes a metabolic activation of mesocorti
cal and some mesolimbic dopaminergic systems with little effect on the
nigrostriatal system. We have examined the ability of an antagonist o
f the allosteric glycine site of the N-methyl-D-aspartate receptor com
plex to block the stress-induced response in dopamine utilization. Thi
rty minutes of restraint stress elevated dopamine metabolism, as measu
red by the ratio between 3,4-dihydroxyphenylacetic acid (DOPAC) and do
pamine, in both the medial prefrontal cortex and nucleus accumbens. An
antagonist for the glycine/N-methyl-D -aspartate receptor complex, 1-
hydroxy-3-aminopyrrolidone-2 ((+)-HA-966), given systemically or injec
ted into the ventral tegmental area, prevents the stress-induced incre
ase in dopamine metabolism in the prefrontal cortex without altering t
he response in the nucleus accumbens. Similarly, systemic administrati
on of the non-competitive antagonist for the N-methyl-D-aspartate rece
ptor, dizocilpine ((+)-MK-801), blocked the stress-induced rise in dop
amine metabolism in the medial prefrontal cortex but not the nucleus a
ccumbens. The negative enantiomer of HA-966 did not produce a selectiv
e antagonism of the stress-induced dopamine metabolism in the medial p
refrontal cortex. These results support previous work which suggest th
e mesocortical and mesoaccumbens dopamine neurons respond to excitator
y input through different glutamate receptor mechanisms. Additionally,
the specific blockade of the stress-induced change in dopamine metabo
lism in the medial prefrontal cortex by a glycine antagonist implies a
role for such an antagonist in treatment of disease states which may
involve disruptions of N-methyl-D-aspartate receptor function.